Search
for
Sort by
Research 751–780 of 1000+
- Color-transition sign: A useful trichoscopic finding for differentiating alopecia areata incognita from telogen effluvium
- Down-RANKing the Threat of HSV-1: RANKL Upregulates MHC-Class-I-Restricted Anti-Viral Immunity in Herpes Simplex Virus Infection
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Mechanism of PPARα agonist in alopecia areata
- Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Alopecia Areata and Alopecia Areata Incognita
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- 861 Frontal fibrosing alopecia (FFA) under dynamic optical coherence tomography (D-OCT)
- Chemotherapy and Cutaneous Drug Reactions
- Serum levels of minerals and vitamins in two categories of female alopecia subjects using hair relaxer
- Primary cicatricial alopecias
- Circular approach for the sustainable valorization of IMTA Codium sp. for multitarget skin care applications
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Evidence based homoeopathy: A case report on androgenic alopecia in 23 year old male
- Exploring the association between alopecia areata and thyroid dysfunction: A review
- Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Psychological burden of alopecia areata in patients with cancer: A narrative review
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Evidence for the off-label use of tofacitinib in alopecia areata
- Assessment of Thyroid Dysfunction and Cortisol Levels in Patients with Alopecia Areata
- Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill)
- Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment
- Treatment of alopecia areata with JAK inhibitors: a review of the literature